NCT01298310View on ClinicalTrials.gov

A Study to Characterize the Phenotype in Patients With Morton's Neuroma and to Explore the Effect of Local Administration of Xylocaine (Lidocaine)

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Morton's Neuroma
Interventions
DRUG

Xylocaine

1 mg/mL solution for injection

DRUG

Xylocaine

10 mg/mL solution for injection

DRUG

Placebo

solution for injection

Trial Locations (1)

Unknown

Research Site, Stockholm

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY